Polyphenol fraction of extra virgin olive oil protects against endothelial dysfunction induced by high glucose and free fatty acids through modulation of nitric oxide and endothelin-1

Redox Biology

Volumn 2, Issue 1, 2014, Pages 971-977

  Storniolo, Carolina Emilia ^a   Roselló Catafau, Joan ^b   Pintó, Xavier ^c   Mitjavila, María Teresa ^a   Moreno, Juan José ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Cell oxidative stress; ECV304 cells; Hyperglycemia; Linoleic acid; Oleic acid; Reactive oxygen species; Type 2 diabetes

Indexed keywords

ACETYLCHOLINE; CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; EXTRA VIRGIN OLIVE OIL; FATTY ACID; GLUCOSE; HYDROXYTYROSOL; LINOLEIC ACID; NITRIC OXIDE; OLEIC ACID; POLYPHENOL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VEGETABLE OIL; POLYPHENOL DERIVATIVE; NOS3 PROTEIN, HUMAN; OLIVE OIL;

ARTICLE; CALCIUM CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; ECV304 CELL LINE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; CONCENTRATION RESPONSE; DRUG MECHANISM; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL LINE; CHEMISTRY; METABOLISM; PATHOLOGY;

CELL LINE; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; ENDOTHELIN-1; FATTY ACIDS, NONESTERIFIED; GLUCOSE; LINOLEIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OLEIC ACID; OLIVE OIL; POLYPHENOLS;

EID: 84908662080     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.07.001     Document Type: Article

References (49)

1. Keys A., Menotti A., Karvonen M.J., Aravanis C., Blackburn H., Buzina R., Djordjevic B.S., Dontas A.S., Fidanza F., Keys M.H. The diet and 15-year death rate in the Seven Countries Study. American Journal of Epidemiology 1986, 124:903-915. http://www.ncbi.nlm.nih.gov/pubmed/3776973.
2. Kris-Etherton P.M., Hecker K.D., Bonanome A., Coval S.M., Binkoski A.E., Hilpert K.F., Griel A.E., Etherton T.D. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. American Journal of Medicine 2002, 113(Suppl. 9B):71S-88S. http://www.ncbi.nlm.nih.gov/pubmed/12566142, 10.1016/j.redox.2014.07.001.
3. Strazzullo P., Ferro-Luzzi A., Siani A., Scaccini C., Sette S., Catasta G., Mancini M. Changing the Mediterranean diet: effects on blood pressure. Journal of Hypertension 1986, 4:407-412. http://www.ncbi.nlm.nih.gov/pubmed/3534087, 10.1016/j.redox.2014.07.001.
4. Estruch R., Ros E., Salas-Salvadó J., Covas M.I., Corella D., Arós F., Gómez-Gracia E., Ruiz-Gutiérrez V., Fiol M., Lapetra J., Lamuela-Raventos R.M., Serra-Majem L., Pintó X., Basora J., Muñoz M.A., Sorlí J.V., Martínez J.A., Martínez-González M.A. Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine 2013, 368:1279-1290. http://www.ncbi.nlm.nih.gov/pubmed/23432189, 10.1016/j.redox.2014.07.001.
5. Estruch R., Martínez-González M.A., Corella D., Salas-Salvadó J., Ruiz-Gutiérrez V., Covas M.I., Fiol M., Gómez-Gracia E., López-Sabater M.C., Vinyoles E., Arós F., Conde M., Lahoz C., Lapetra J., Sáez G., Ros E. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Annals of Internal Medicine 2006, 145:1-11. http://www.ncbi.nlm.nih.gov/pubmed/16818923, 10.1016/j.redox.2014.07.001.
6. Toledo E., Hu F.B., Estruch R., Buil-Cosiales P., Corella D., Salas-Salvadó J., Covas M.I., Arós F., Gómez-Gracia E., Fiol M., Lapetra J., Serra-Majem L., Pinto X., Lamuela-Raventós R.M., Saez G., Bulló M., Ruiz-Gutiérrez V., Ros E., Sorli J.V., Martinez-Gonzalez M.A. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC Medicine 2013, 11:207. http://www.ncbi.nlm.nih.gov/pubmed/24050803, 10.1016/j.redox.2014.07.001.
7. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:9265-9269. http://www.ncbi.nlm.nih.gov/pubmed/2827174, 10.1016/j.redox.2014.07.001.
8. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415. http://www.ncbi.nlm.nih.gov/pubmed/2451132, 10.1016/j.redox.2014.07.001.
9. Lüscher T.F., Yang Z., Tschudi M., von Segesser L., Stulz P., Boulanger C., Siebenmann R., Turina M., Bühler F.R. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circulation Research 1990, 66:1088-1094. http://www.ncbi.nlm.nih.gov/pubmed/2180587, 10.1016/j.redox.2014.07.001.
10. Ding H., Triggle C.R. Endothelial dysfunction in diabetes: multiple targets for treatment. Pflügers Archiv: European Journal of Physiology 2010, 459:977-994. http://www.ncbi.nlm.nih.gov/pubmed/20238124, 10.1016/j.redox.2014.07.001.
11. Imrie H., Abbas A., Kearney M. Insulin resistance, lipotoxicity and endothelial dysfunction. Biochimica et Biophysica Acta 2010, 1801:320-326. http://www.ncbi.nlm.nih.gov/pubmed/19818873, 10.1016/j.redox.2014.07.001.
12. Monti L.D., Landoni C., Setola E., Galluccio E., Lucotti P., Sandoli E.P., Origgi A., Lucignani G., Piatti P., Fazio F. Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients. American Journal of Physiology: Heart and Circulatory Physiology 2004, 287:H1225-H1231. http://www.ncbi.nlm.nih.gov/pubmed/15130883, 10.1016/j.redox.2014.07.001.
13. Medina-Remón A., Barrionuevo-González A., Zamora-Ros R., Andres-Lacueva C., Estruch R., Martínez-González M.A., Diez-Espino J., Lamuela-Raventos R.M. Rapid folin-ciocalteu method using microtiter 96-well plate cartridges for solid phase extraction to assess urinary total phenolic compounds, as a biomarker of total polyphenols intake. Analytica Chimica Acta 2009, 634:54-60. http://www.ncbi.nlm.nih.gov/pubmed/19154810, 10.1016/j.redox.2014.07.001.
14. Moreno J.J. Antiflammin-2 prevents HL-60 adhesion to endothelial cells and prostanoid production induced by lipopolysaccharides. Journal of Pharmacology and Experimental Therapeutics 2001, 296:884-889. http://www.ncbi.nlm.nih.gov/pubmed/11181920.
15. Kalyanaraman B., Darley-Usmar V., Davies K.J., Dennery P.A., Forman H.J., Grisham M.B., Mann G.E., Moore K., Roberts L.J., Ischiropoulos H. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radical Biology & Medicine 2012, 52:1-6. http://www.ncbi.nlm.nih.gov/pubmed/22027063, 10.1016/j.redox.2014.07.001.
16. Wardman P. Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radical Biology & Medicine 2007, 43:995-1022. http://www.ncbi.nlm.nih.gov/pubmed/17761297, 10.1016/j.redox.2014.07.001.
17. Wymann M.P., Bulgarelli-Leva G., Zvelebil M.J., Pirola L., Vanhaesebroeck B., Waterfield M.D., Panayotou G. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of lys-802, a residue involved in the phosphate transfer reaction. Molecular and Cellular Biology 1996, 16:1722-1733. http://www.ncbi.nlm.nih.gov/pubmed/8657148.
18. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:7686-7689. http://www.ncbi.nlm.nih.gov/pubmed/7644477.
19. Frantz B., Klatt T., Pang M., Parsons J., Rolando A., Williams H., Tocci M.J., O'Keefe S.J., O'Neill E.A. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 1998, 37:13846-13853. http://www.ncbi.nlm.nih.gov/pubmed/9753474, 10.1016/j.redox.2014.07.001.
20. Rodríguez-Lagunas M.J., Martín-Venegas R., Moreno J.J., Ferrer R. PGE2 promotes Ca2+-mediated epithelial barrier disruption through EP1 and EP4 receptors in Caco-2 cell monolayers. American Journal of Physiology. Cell Physiology 2010, 299:C324-C334. http://www.ncbi.nlm.nih.gov/pubmed/20484658, 10.1016/j.redox.2014.07.001.
21. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry 1985, 260:3440-3450. http://www.ncbi.nlm.nih.gov/pubmed/3838314.
22. Abid M.R., Kachra Z., Spokes K.C., Aird W.C. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Letters 2000, 486:252-256. http://www.ncbi.nlm.nih.gov/pubmed/11119713, 10.1016/j.redox.2014.07.001.
23. Schächinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899-1906. http://www.ncbi.nlm.nih.gov/pubmed/10779454.
24. Bugiardini R., Manfrini O., Pizzi C., Fontana F., Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 2004, 109:2518-2523. http://www.ncbi.nlm.nih.gov/pubmed/15136498, 10.1016/j.redox.2014.07.001.
25. Kuroda R., Hirata K., Kawashima S., Yokoyama M. Unsaturated free fatty acids inhibit Ca2+ mobilization and NO release in endothelial cells. Kobe Journal of Medical Sciences 2001, 47:211-219. http://www.ncbi.nlm.nih.gov/pubmed/11781499.
26. Kim F., Tysseling K.A., Rice J., Pham M., Haji L., Gallis B.M., Baas A.S., Paramsothy P., Giachelli C.M., Corson M.A., Raines E.W. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKβ. Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 25:989-994. http://www.ncbi.nlm.nih.gov/pubmed/15731493, 10.1016/j.redox.2014.07.001.
27. Kopf T., Schmitz G. Analysis of non-esterified fatty acids in human samples by solid-phase-extraction and gas chromatography/mass spectrometry. Journal of Chromatography 2013, 938:22-26. http://www.ncbi.nlm.nih.gov/pubmed/24036177, 10.1016/j.redox.2014.07.001.
28. Du X.L., Edelstein D., Obici S., Higham N., Zou M.H., Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. Journal of Clinical Investigation 2006, 116:1071-1080. http://www.ncbi.nlm.nih.gov/pubmed/16528409, 10.1016/j.redox.2014.07.001.
29. Wong W.T., Tian X.Y., Xu A., Ng C.F., Lee H.K., Chen Z.Y., Au C.L., Yao X., Huang Y. Angiotensin II type 1 receptor-dependent oxidative stress mediates endothelial dysfunction in type 2 diabetic mice. Antioxidants & Redox Signaling 2010, 13:757-768. http://www.ncbi.nlm.nih.gov/pubmed/20136508, 10.1016/j.redox.2014.07.001.
30. Liu S., Ma X., Gong M., Shi L., Lincoln T., Wang S. Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Free Radical Biology & Medicine 2007, 42:852-863. http://www.ncbi.nlm.nih.gov/pubmed/17320767, 10.1016/j.redox.2014.07.001.
31. Heumüller S., Wind S., Barbosa-Sicard E., Schmidt H.H., Busse R., Schröder K. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008, 51:211-217. http://www.ncbi.nlm.nih.gov/pubmed/18086956, 10.1016/j.redox.2014.07.001.
32. Patel H., Chen J., Das K.C., Kavdia M. Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC. Cardiovascular Diabetology 2013, 12:142. http://www.ncbi.nlm.nih.gov/pubmed/24093550, 10.1016/j.redox.2014.07.001.
33. Serizawa K., Yogo K., Aizawa K., Tashiro Y., Ishizuka N. Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats. Cardiovascular Diabetology 2011, 10:105. http://www.ncbi.nlm.nih.gov/pubmed/22107602, 10.1016/j.redox.2014.07.001.
34. Liu J.C., Chen J.J., Chan P., Cheng C.F., Cheng T.H. Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 2003, 42:1198-1205. http://www.ncbi.nlm.nih.gov/pubmed/14623829, 10.1016/j.redox.2014.07.001.
35. Du X.L., Edelstein D., Dimmeler S., Ju Q., Sui C., Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. Journal of Clinical Investigation 2001, 108:1341-1348. http://www.ncbi.nlm.nih.gov/pubmed/11696579, 10.1016/j.redox.2014.07.001.
36. Wallis M.G., Smith M.E., Kolka C.M., Zhang L., Richards S.M., Rattigan S., Clark M.G. Acute glucosamine-induced insulin resistance in muscle in vivo is associated with impaired capillary recruitment. Diabetologia 2005, 48:2131-2139. http://www.ncbi.nlm.nih.gov/pubmed/16059714, 10.1016/j.redox.2014.07.001.
37. Cardillo C., Campia U., Bryant M.B., Panza J.A. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 2002, 106:1783-1787. http://www.ncbi.nlm.nih.gov/pubmed/12356630, 10.1016/j.redox.2014.07.001.
38. Medina-Remón A., Zamora-Ros R., Rotchés-Ribalta M., Andres-Lacueva C., Martínez-González M.A., Covas M.I., Corella D., Salas-Salvadó J., Gómez-Gracia E., Ruiz-Gutiérrez V., García de la Corte F.J., Fiol M., Pena M.A., Saez G.T., Ros E., Serra-Majem L., Pinto X., Warnberg J., Estruch R., Lamuela-Raventos R.M. Total polyphenol excretion and blood pressure in subjects at high cardiovascular risk. Nutrition, Metabolism and Cardiovascular Diseases 2011, 21:323-331. PREDIMED Study Investigators. http://www.ncbi.nlm.nih.gov/pubmed/20167460, 10.1016/j.redox.2014.07.001.
39. Tresserra-Rimbau A., Medina-Remón A., Pérez-Jiménez J., Martínez-González M.A., Covas M.I., Corella D., Salas-Salvadó J., Gómez-Gracia E., Lapetra J., Arós F., Fiol M., Ros E., Serra-Majem L., Pintó X., Muñoz M.A., Saez G.T., Ruiz-Gutiérrez V., Warnberg J., Estruch R., Lamuela-Raventós R.M. Dietary intake and major food sources of polyphenols in a Spanish population at high cardiovascular risk: the PREDIMED study. Nutrition, Metabolism and Cardiovascular Diseases 2013, 23:953-959. http://www.ncbi.nlm.nih.gov/pubmed/23332727, 10.1016/j.redox.2014.07.001.
40. Nicholson S.K., Tucker G.A., Brameld J.M. Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. British Journal of Nutrition 2010, 103:1398-1403. http://www.ncbi.nlm.nih.gov/pubmed/20021702, 10.1016/j.redox.2014.07.001.
41. Weinbrenner T., Fitó M., Farré Albaladejo M., Saez G.T., Rijken P., Tormos C., Coolen S., De la Torre R., Covas M.I. Bioavailability of phenolic compounds from olive oil and oxidative/antioxidant status at postprandial state in healthy humans. Drugs Under Experimental and Clinical Research 2004, 30:207-212. http://www.ncbi.nlm.nih.gov/pubmed/15700748.
42. Atochin D.N., Wang A., Liu V.W., Critchlow J.D., Dantas A.P., Looft-Wilson R., Murata J., Salomone S., Shin H.K., Avata C., Moskowitz H.A. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. Journal of Clinical Investigation 2007, 117:1961-1967. http://www.ncbi.nlm.nih.gov/pubmed/17557122, 10.1016/j.redox.2014.07.001.
43. Fleming I. Molecular mechanisms underlying the activation of eNOS. Pflügers Archiv: European Journal of Physiology 2010, 459:793-806. http://www.ncbi.nlm.nih.gov/pubmed/20012875, 10.1016/j.redox.2014.07.001.
44. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605. http://www.ncbi.nlm.nih.gov/pubmed/10376603, 10.1016/j.redox.2014.07.001.
45. Anter E., Thomas S.R., Schulz E., Shapira O.M., Vita J.A., Keaney J.F. Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. Journal of Biological Chemistry 2004, 279:46637-46643. http://www.ncbi.nlm.nih.gov/pubmed/15333638, 10.1016/j.redox.2014.07.001.
46. Anter E., Chen K., Shapira O.M., Karas R.H., Keaney J.F. p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor α-dependent pathway in response to black tea polyphenols. Circulation Research 2005, 96:1072-1078. http://www.ncbi.nlm.nih.gov/pubmed/15879307, 10.1016/j.redox.2014.07.001.
47. Vouyouka A.G., Jiang Y., Rastogi R., Basson M.D. Ambient pressure upregulates nitric oxide synthase in a phosphorylated-extracellular regulated kinase- and protein kinase C-dependent manner. Journal of Vascular Surgery 2006, 44:1076-1084. http://www.ncbi.nlm.nih.gov/pubmed/17098545, 10.1016/j.redox.2014.07.001.
48. Martin S., Andriambeloson E., Takeda K., Andriantsitohaina R. Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. British Journal of Pharmacology 2002, 135:1579-1587. http://www.ncbi.nlm.nih.gov/pubmed/11906973, 10.1016/j.redox.2014.07.001.
49. Brown J., Reading S.J., Jones S., Fitchett C.J., Howl J., Martin A., Longland C.L., Michelangeli F., Dubrova Y.E., Brown C.A. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Laboratory Investigation 2000, 80:37-45. http://www.ncbi.nlm.nih.gov/pubmed/10653001, 10.1016/j.redox.2014.07.001.